Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement News, In Brief

Executive Summary

HHS delays state deadlines for committing to insurance exchanges, PCORI solicits research applications and Walgreens study measures medication adherence.

You may also be interested in...



Methods Research Dominates PCORI Pilot Projects

The Patient-Centered Outcomes Research Institute announced the awardees of pilot project research funds, with many winners emphasizing research that advances the methodology of conducting patient-centered outcomes research.

PCORI Plans Detailed Funding Announcement For One Area Of Research Agenda

The overall Patient-Centered Outcomes Research Institute’s research agenda offered five broad areas where it will be seeking to fund research. While four of those areas will remain broadly defined when PCORI solicits study proposals through a PCORI funding announcement in May, the PFA in the area of accelerating patient-centered outcomes research and methodological research will add some specifics on types of studies needed and be issued in July.

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel